Resources
78 Results (showing 1 - 10)
Results sorted by posted date (newest first)
Results sorted by posted date (newest first)
Posted 4/26/2024
The Nitazenes Overview resource created by RCORP-TA describes what nitazenes are, how to determine if they are in your community, and how to prevent and respond to overdoses due to nitazenes. Additional resources are also provided to learn more about nitazenes.
Posted 3/29/2024
A planning committee of the National Academies of Sciences, Engineering, and Medicine organized and conducted a two-day virtual public workshop that brought together data experts, program implementers and evaluators, and other key interested parties to explore data collection efforts, evidence gaps, and research needs on harm reduction for people who use drugs (PWUD).
Posted 12/15/2023 (updated 3/28/2024)
The Opioid-Overdose Reduction Continuum of Care Approach is a guide for policymakers for implementing evidence-based strategies that address opioid overdose.
Posted 11/9/2023 (updated 3/28/2024)
The Substance Abuse and Mental Health Services Administration (SAMHSA) published Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants in 2018. The National Center on Substance Abuse and Child Welfare (NCSACW) developed companion materials that offer information and strategies to support pregnant and parenting people with substance use disorders (SUDs) in the child welfare system.
Posted 10/19/2023 (updated 4/11/2024)
Implementation IV grantees with tools and strategies
Posted 9/29/2023 (updated 3/27/2024)
The 2023 RCORP-Overdose Response Onboarding Packet contains strategies and resources to assist grantees in the implementation of your new Overdose Response (OR) grant. The Onboarding Packet includes tools to support grant-funded activities, along with information on accessing TA.
Posted 7/31/2023 (updated 3/26/2024)
At the end of July 2023, the U.S. Food and Drug Administration approved a second over-the-counter naloxone nasal spray product, RiVive. The agency who received the approval to manufacture the product, Harm Reduction Therapeutics, does not yet have a timeline of availability and decision on pricing.
Posted 7/26/2023 (updated 3/28/2024)
The FY22 RCORP-Implementation cohort is diverse and dynamic in every way, representing a wide variety of experience and possessing an unending amount of knowledge on SUD in rural areas. This session explored the different methods and practices this cohort uses in its efforts to address SUD prevention, treatment, and recovery. Participants had an opportunity to learn from and to build relationships with one another, which will, in turn strengthen, their RCORP projects. Additionally, they heard from RCORP program staff and the RCORP-Evaluation team about program updates and data utilization tools.
Posted 7/26/2023 (updated 3/28/2024)
This session focused on FY 21 RCORP-Implementation III. Grantees received an overview of the upcoming Sustainability Plan Year 2 deliverable, including a walkthrough of the template.
Posted 7/26/2023 (updated 3/28/2024)
During this session, the Fiscal Year 2020 (FY20) RCORP-Implementation grantees had an opportunity to share best practices, identify the impact that the RCORP grant had in their communities, learned how to use the data collected in the data dashboard, and network with other grantees. In addition, grantees received important information pertaining to evaluation, upcoming deliverables, sustainability and next steps.